IL17A and myeloid sarcoma: Furthermore, an increased percentage of TH17 cells and mRNA levels of IL-17 were described in brain lesions of MS patients as compared to HC [50]; in fact, an enrichment of IL-17-producing T cells of >70% was found in active MS lesions in comparison to 17% in inactive plaques [51].